Glucose Metabolism News and Research

RSS

Microfluidics chips for simplifying medical imaging biomarkers of disease

A collaboration between scientists at UCLA, Caltech, Stanford, Siemens and Fluidigm have developed a new technology using integrated microfluidics chips for simplifying, lowering the cost and diversifying the types of molecules used to image the biology of disease with the medical imaging technology, Positron Emission Tomography (PET).

15 Dec 2005

How protein-enriched meals decrease hunger and reduce eating

Researchers have uncovered new evidence to explain the observation that diets rich in protein stunt the appetite, according to a report in the November Cell Metabolism.

13 Nov 2005

Combining fMRI and PET scanning creates a way to compare different measurements of the brain's function concurrently

Clinical researchers from the University of Pennsylvania Health System (UPHS) are the first to combine fMRI and PET scanning in radiology, creating a way to compare different measurements of the brain's function concurrently. This analysis could lead to better diagnosis and treatment in patients suffering from brain disorders, like Alzheimer's disease.

12 Oct 2005

PET imaging with FDG represents one of the most promising tools for diagnosis of Alzheimer's

Positron emission tomography (PET) imaging--with the radiotracer fluorodeoxyglucose (FDG)--is a promising tool in detecting Alzheimer's disease in patients who have mild cognitive impairment (MCI), according to a study reported in the October issue of the Society of Nuclear Medicine's Journal of Nuclear Medicine.

5 Oct 2005

Increasing sugar processing in the liver may lead to future treatments for diabetes, obesity

Researchers at the University of Minnesota have shown that increasing the concentration of a key regulator involved in glucose metabolism can improve the way the liver produces and disposes of the sugar glucose, the primary fuel of the body. Finding ways to increase that concentration could provide a treatment for diabetes and obesity.

22 Aug 2005

Losing weight cuts breast cancer risk

An international team of scientists has found that young women who carry a breast cancer gene, can reduce their risk of the disease by up to 65% by attaining a healthy bodyweight.

21 Aug 2005

Protein Sirt1 points to new therapies for type 2 diabetes

Opening the possibility of new therapies for type 2 diabetes, researchers at Washington University School of Medicine in St. Louis have found that a protein called Sirt1 enhances the secretion of insulin in mice and allows them to better control blood glucose levels. Their study appears in the August 17 issue of Cell Metabolism.

18 Aug 2005

Combined computed tomography (CT) and positron emission tomography (PET) - may detect the spread of head and neck cancer more accurately

"PET/CT is very helpful in determining where we should pinpoint our biopsies for recurrent disease," said Dr. Carol Shores, assistant professor of otolaryngology/head and neck surgery at UNC and the report's senior author. Shores is a member of the UNC Lineberger Comprehensive Cancer Center.

26 Jul 2005

Heart attack patients: shedding pounds reduces risks

Heart attack patients with diabetes or a cluster of cardiovascular risk factors known as metabolic syndrome have an increased risk of another heart attack, stroke or death, but patients who lost weight after their heart attacks were less likely to become diabetic, according to a new study in the July 19, 2005, issue of the Journal of the American College of Cardiology.

21 Jul 2005

Exercise helps find genetic regions linked to prediabetes

People's bodies respond to exercise in different ways, and their genetic makeup is partly responsible.

28 Jun 2005

PET might be a promising tool for early prediction of response to chemotherapy for ovarian can

Noninvasive positron emission tomography (PET) imaging may allow earlier prediction of a patient's response to chemotherapy for ovarian cancer, according to research reported at the Society of Nuclear Medicine's 52nd Annual Meeting June 18–22 in Toronto.

20 Jun 2005

First demonstration that reduced metabolic activity in the hippocampus may be used to help predict future Alzheimer's disease

New York University School of Medicine researchers have developed a brain scan-based computer program that quickly and accurately measures metabolic activity in a key region of the brain affected in the early stages of Alzheimer's disease.

19 Jun 2005

A drug that controls blood pressure and reduces heart risk also appears to protect against diabetes

In new results from the VALUE trial that pitted the drug valsartan against another blood pressure drug, amlodipine, the patients taking valsartan were found to have a 23 percent lower risk of developing diabetes during the four or more years of the study.

18 May 2005

New findings about insulin-signaling in the liver could prove useful in understanding type 2 diabetes

A collaborative effort led by The Burnham Institute's Gen-Sheng Feng has created a mouse with improved glucose tolerance and insulin activity in the liver, and generated new findings about insulin-signaling in the liver that could prove useful in understanding the pathogenesis of type 2 diabetes.

12 Apr 2005

Pediatric burn victims’ recovery, diabetes aided by Fenofibrate

One of the immediate serious results of sudden extreme trauma or stress, including burns and even surgery, is insulin resistance, or diabetes. As a result, healing is delayed, especially in the case of severe burns, and since the body is unable to fully use blood sugar for energy, muscle tissue is broken down as the body scavenges for other possible energy sources.

3 Apr 2005

Diabetes Busting Burgers!

Chemists with the U.S. Department of Agriculture recently presented a preliminary report to the 229th national meeting of the American Chemical Society, in which they say they have discovered a form of soluble cellulose that, if added to high-fat food. The new finding could soon benefit people who regularly eat fast-foods that are high in fat.

16 Mar 2005

New genomic, proteomic tools yield clues to exercise/diet effects on obesity, metabolic syndrome and diabetes

Applying the latest genomic and proteomic techniques has given researchers new clues for the interaction between exercise and diet, glucose metabolism and improvement in cardiovascular disease (CVD) risk factors.

5 Oct 2004

Patent pending discovery could help type 2 diabetics

Scientists from MitoChroma Research have recently announced a patent-pending discovery that could complement current medical management modalities for Type 2 Diabetes, insulin resistance and the set of related conditions called "Metabolic Syndrome."

4 Oct 2004

Slimming agents could pose major health risk

Commonly used nutritional supplements and body-building agents for elite athletes could pose an increased risk of cancer according to a study undertaken at the University of Sydney.

16 Sep 2004

Summary of The Euro Heart Survey on the diabetic state of patients with coronary artery disease

The survey engaged 110 centres in 25 countries recruiting 4,196 patients referred to a cardiology department or outpatient clinic due to CAD. A total of 2 107 of these patients were admitted on acute basis while 2,854 had an elective consultation. Patient data were collected via a web-based case record form.

30 Aug 2004